NCT01736423View on ClinicalTrials.gov

A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Diarrhea-predominant Irritable Bowel Syndrome
Interventions
DRUG

YM060

oral

Trial Locations (4)

Unknown

Hokkaido

Kansai

Kantou

Kyushu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01736423 - A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter